CIK 0001372514
- Non-accelerated filer
- Smaller reporting company
KIORA PHARMACEUTICALS INC
Sign in to watch- Tickers
- KPRX KPHMW
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980443284
- Phone
- +1 858-224-9600
- Business address
- 169 SAXONY RD., SUITE 212, ENCINITAS, CA, 92024
- Former names
- EYEGATE PHARMACEUTICALS INC
Securities
- KPRX Common Stock Nasdaq
- KPHMW Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 73 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-04-17 | Garanzini Michael Chief Commercial Officer | Purchase | +156,250 | 171,250 | ||
| 2018-04-17 | Garanzini Michael Chief Commercial Officer | Purchase · Warrants (right to buy) | +156,250 | 156,250 | ||
| 2018-04-17 | FROM STEPHEN President and CEO | Purchase | +125,000 | 409,820 | ||
| 2018-04-17 | FROM STEPHEN President and CEO | Purchase · Warrants (right to buy) | +125,000 | 125,000 | ||
| 2018-04-17 | Romano Sarah Chief Financial Officer | Purchase | +62,500 | 106,863 | ||
| 2018-04-17 | Romano Sarah Chief Financial Officer | Purchase · Warrants (right to buy) | +62,500 | 62,500 | ||
| 2018-04-17 | ARMISTICE CAPITAL, LLC 10% owner | Purchase | +1,895,610 | $0.44 | $838K | 13,712,500 |
| 2018-04-17 | ARMISTICE CAPITAL, LLC 10% owner | Purchase | +0 | 13,712,500 | ||
| 2018-04-17 | ARMISTICE CAPITAL, LLC 10% owner | Purchase | +0 | 13,712,500 | ||
| 2018-04-16 | ARMISTICE CAPITAL, LLC 10% owner | Purchase | +1,159,167 | $0.38 | $436K | 11,816,890 |
| 2018-04-16 | ARMISTICE CAPITAL, LLC 10% owner | Purchase | +0 | 11,816,890 | ||
| 2018-04-16 | ARMISTICE CAPITAL, LLC 10% owner | Purchase | +0 | 11,816,890 | ||
| 2018-04-16 | ARMISTICE CAPITAL, LLC 10% owner | Purchase · Warrants | +5,468,750 | $0.21 | $1.1M | 5,468,750 |
| 2018-04-16 | ARMISTICE CAPITAL, LLC 10% owner | Purchase · Warrants | +0 | 5,468,750 | ||
| 2018-04-16 | ARMISTICE CAPITAL, LLC 10% owner | Purchase · Warrants | +0 | 5,468,750 | ||
| 2018-04-13 | ARMISTICE CAPITAL, LLC 10% owner | Purchase | +7,425,193 | $0.33 | $2.5M | 10,657,723 |
| 2018-04-13 | ARMISTICE CAPITAL, LLC 10% owner | Purchase | +0 | 10,657,723 | ||
| 2018-04-13 | ARMISTICE CAPITAL, LLC 10% owner | Purchase | +0 | 10,657,723 | ||
| 2018-02-28 | Romano Sarah Chief Financial Officer | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2018-02-28 | Mann Brenda VP of Research & Development | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 |
Page 21 of 24 · 468 trades